Works matching IS 08991987 AND DT 2024 AND VI 63 AND IP 4

Results: 21

NT5DC2 knockdown suppresses progression, glycolysis, and neuropathic pain in triple‐negative breast cancer by blocking the EGFR pathway.

Published in:

Molecular Carcinogenesis, 2024, v. 63, n. 4, p. 785, doi. 10.1002/mc.23688

By:

Sang, Rui;
Yu, Xiaoping;
Xia, Han;
Qian, Xingxing;
Yong, Jiacheng;
Xu, Yan;
Sun, Yan;
Yao, Yiran;
Zhou, Jing;
Zhuo, Shuangshuang

Publication type:

Article

Corrigendum to "Nexrutine inhibits azoxymethane‐induced colonic aberrant crypt formation in rat colon and induced apoptotic cell death in colon adenocarcinoma cells".

Published in:: Molecular Carcinogenesis, 2024, v. 63, n. 4, p. 797, doi. 10.1002/mc.23707
Publication type:: Article

Liensinine inhibits progression of intrahepatic cholangiocarcinoma by regulating TGF‐β1 /P‐smad3 signaling through HIF‐1a.

Published in:

Molecular Carcinogenesis, 2024, v. 63, n. 4, p. 772, doi. 10.1002/mc.23687

By:

Zhu, Xuewen;
Bao, Wenming;
Xie, Xiaozai;
Chen, Bo;
Li, Rizhao;
Zhao, Jungang;
Wu, Lijun;
Yu, Zhengping;
Li, Shi;
Zhu, Qiandong;
Chen, Gang;
Li, Jiacheng

Publication type:

Article

Silencing lncRNA‐DARS‐AS1 suppresses nonsmall cell lung cancer progression by stimulating miR‐302a‐3p to inhibit ACAT1 expression.

Published in:

Molecular Carcinogenesis, 2024, v. 63, n. 4, p. 757, doi. 10.1002/mc.23686

By:

Li, Ji;
Li, Yizhuo;
Sun, Xiaodan;
Wei, Lai;
Guan, Jingqian;
Fu, Lin;
Du, Jiang;
Zhang, Xiupeng;
Cheng, Ming;
Ma, Huan;
Jiang, Siyu;
Zheng, Qianqian;
Wang, Liang

Publication type:

Article

SN‐38, an active metabolite of irinotecan, inhibits transcription of nuclear factor erythroid 2‐related factor 2 and enhances drug sensitivity of colorectal cancer cells.

Published in:

Molecular Carcinogenesis, 2024, v. 63, n. 4, p. 742, doi. 10.1002/mc.23685

By:

Wang, Jingya;
Xu, Jiangli;
Yang, Shuhui;
He, Liu;
Xu, Wenhuai;
Liu, Yan'e;
Cao, Baoshan;
Yu, Siwang

Publication type:

Article

SSBP1 is a novel prognostic marker and promotes disease progression via p38MAPK signaling pathway in multiple myeloma.

Published in:

Molecular Carcinogenesis, 2024, v. 63, n. 4, p. 728, doi. 10.1002/mc.23684

By:

Xiao, Pingping;
Wang, Jizhen;
Li, Tingting;
Yang, Apeng;
Qiu, Dongbiao;
Chen, Junmin;
Zeng, Zhiyong

Publication type:

Article

Breast cancer malignancy is governed by regulation of the macroH2A2/TM4SF1 axis, the AKT/NF‐κB pathway, and elevated MMP13 expression.

Published in:

Molecular Carcinogenesis, 2024, v. 63, n. 4, p. 714, doi. 10.1002/mc.23683

By:

Jin, Yunho;
Eum, Da‐Young;
Lee, Chaeyoung;
Park, Soon Yong;
Shim, Jae Woong;
Choi, Yoo Jin;
Choi, Si Ho;
Kim, Joong‐Gook;
Heo, Kyu;
Park, Seong‐Joon

Publication type:

Article

Sciellin promotes the development and progression of thyroid cancer through the JAK2/STAT3 signaling pathway.

Published in:

Molecular Carcinogenesis, 2024, v. 63, n. 4, p. 701, doi. 10.1002/mc.23682

By:

Guo, Haohao;
Wang, Ziyang;
Yin, Keyu;
Ma, Runsheng;
Zhang, Yifei;
Yin, Fanxiang;
Li, Hongqiang;
Yin, Detao

Publication type:

Article

The FOXO1/G6PC axis promotes gastric cancer progression and mediates 5‐fluorouracil resistance by targeting the PI3K/AKT/mTOR signaling pathway.

Published in:

Molecular Carcinogenesis, 2024, v. 63, n. 4, p. 688, doi. 10.1002/mc.23681

By:

Han, Anna;
Liu, Taorui;
Du, Pan;
Wang, Mengying;
Liu, Jiajing;
Chen, Liyan

Publication type:

Article

Comprehensive analysis of m<sup>6</sup>A methylome and transcriptome by Nanopore sequencing in clear cell renal carcinoma.

Published in:

Molecular Carcinogenesis, 2024, v. 63, n. 4, p. 677, doi. 10.1002/mc.23680

By:

Li, Hexin;
Li, Chang;
Zhang, Yuxiang;
Jiang, Weixing;
Zhang, Fubo;
Tang, Xiaokun;
Sun, Gaoyuan;
Xu, Siyuan;
Dong, Xin;
Shou, Jianzhong;
Yang, Yong;
Chen, Meng

Publication type:

Article

BST2 promotes gastric cancer metastasis under the regulation of HOXD9 and PABPC1.

Published in:

Molecular Carcinogenesis, 2024, v. 63, n. 4, p. 663, doi. 10.1002/mc.23679

By:

Li, Jiaying;
Yang, Ping;
Hong, Linjie;
Xiao, Wushuang;
Zhang, Luyu;
Yu, Zhen;
Zhang, Jieming;
Pei, Miaomiao;
Peng, Ying;
Wei, Xiangyang;
Wu, Xiaosheng;
Tang, Weimei;
Zhao, Yingying;
Yang, Juanying;
Lin, Zhizhao;
Jiang, Ping;
Xiang, Li;
Zhang, Hui;
Lin, Jianjiao;
Wang, Jide

Publication type:

Article

ABHD6 suppresses colorectal cancer progression via AKT signaling pathway.

Published in:

Molecular Carcinogenesis, 2024, v. 63, n. 4, p. 647, doi. 10.1002/mc.23678

By:

Xiong, Xiaoyu;
Yang, Changjiang;
Jin, Yiteng;
Zhang, Rui;
Wang, Shuo;
Gan, Lin;
Hou, Sen;
Bao, Yudi;
Zeng, Zexian;
Ye, Yingjiang;
Gao, Zhidong

Publication type:

Article

circRNA TATA‐box binding protein associated factor 15 acts as an oncogene to facilitate bladder cancer progression through targeting miR‐502‐5p/high mobility group box 3.

Published in:

Molecular Carcinogenesis, 2024, v. 63, n. 4, p. 629, doi. 10.1002/mc.23677

By:

Yang, Hong;
He, Peilin;
Luo, Wei;
Liu, Shaoyou;
Yang, Yong

Publication type:

Article

Genetic susceptibility to prostate cancer in Taiwan: A genome‐wide association study.

Published in:

Molecular Carcinogenesis, 2024, v. 63, n. 4, p. 617, doi. 10.1002/mc.23676

By:

Bau, Da‐Tian;
Tsai, Chia‐Wen;
Chang, Wen‐Shin;
Yang, Jai‐Sing;
Liu, Ting‐Yuan;
Lu, Hsing‐Fang;
Wang, Yu‐Wen;
Tsai, Fuu‐Jen

Publication type:

Article

Knockout of Shcbp1 sensitizes immunotherapy by regulating α‐SMA positive cancer‐associated fibroblasts.

Published in:

Molecular Carcinogenesis, 2024, v. 63, n. 4, p. 601, doi. 10.1002/mc.23675

By:

Gu, Qianlin;
Ma, Zhijian;
Wang, Qiaoyan;
Dai, Yiwei;
Shi, Wengui;
Jiao, Zuoyi

Publication type:

Article

Novel two‐tiered screening approach identifies synergistic combinations of natural compounds for prostate cancer prevention and treatment.

Published in:

Molecular Carcinogenesis, 2024, v. 63, n. 4, p. 589, doi. 10.1002/mc.23674

By:

Friedman, Chelsea A.;
Saha, Achinto;
Lavender Hackman, G.;
Lu, Xiyuan;
Lodi, Alessia;
Tiziani, Stefano;
DiGiovanni, John

Publication type:

Article

Nicotinamide mononucleotide induces autophagy and ferroptosis via AMPK/mTOR pathway in hepatocellular carcinoma.

Published in:

Molecular Carcinogenesis, 2024, v. 63, n. 4, p. 577, doi. 10.1002/mc.23673

By:

Sun, Zhanbo;
Liu, Lixian;
Liang, Hongyuan;
Zhang, Lingyun

Publication type:

Article

Identification of concurrent STAT3::RARA and RARA::STAT5b fusions in a variant APL case.

Published in:

Molecular Carcinogenesis, 2024, v. 63, n. 4, p. 558, doi. 10.1002/mc.23672

By:

Tao, Tingting;
Cen, Jiannong;
Xu, Chao;
Chen, Yan;
Cao, Yanglin;
Gong, Yanlei;
Zhu, Mingqing;
Chen, Suning;
Zhang, Qike;
Yao, Li

Publication type:

Article

Venetoclax overcomes resistance to all‐trans retinoic acid in a variant acute promyelocytic leukemia with TNRC18::RARA fusion.

Published in:

Molecular Carcinogenesis, 2024, v. 63, n. 4, p. 553, doi. 10.1002/mc.23671

By:

Xu, Jing;
Li, He;
Wang, Zhongwang;
Wang, Mengyao;
Li, Qian;
Hang, Xiaohang;
Xu, Juan;
Ji, Jie;
Chen, Chong;
Liu, Yu;
Niu, Ting

Publication type:

Article

Mass cytometry and transcriptomic profiling reveal PD1 blockade induced alterations in oral carcinogenesis.

Published in:

Molecular Carcinogenesis, 2024, v. 63, n. 4, p. 563, doi. 10.1002/mc.23670

By:

Dong, Yunmei;
Zhang, Chengli;
Mao, Fei;
Dan, Hongxia;
Zeng, Xin;
Ji, Ning;
Li, Jing;
Chen, Qianming;
Zhou, Yu;
Li, Taiwen

Publication type:

Article

Issue Information ‐ Ed Board.

Published in:: Molecular Carcinogenesis, 2024, v. 63, n. 4, p. 549, doi. 10.1002/mc.23573
Publication type:: Article